# HBI Active Session


## CURRENT AUTHORITATIVE CORRECTION — 2026-11-12

This section supersedes any conflicting statement in older handoff sections below. Older snapshots and comments remain historical records of what was reported at their timestamps; they are not current-state assertions.

### ProductKnowledge transfer — verified operator report
- The 2026-11-12 operator report confirms that exactly seven existing ProductKnowledge rows were updated in a content-only transaction, writing only: `ingredients`, `ingredient_roles`, `claimed_benefits`, `known_use_cases`, `usage_instructions`, `manufacturer_claims`, `contraindications`, and `evidence_refs`.
- The reported transaction passed SQLite integrity (`ok`) with zero FK violations. A pre-write backup was reported at `E:\\HBI_GitHub_Current\\artifacts\\hbi-before-productknowledge-write-20261112-001331.db`.
- The report states that Product, Evidence, Inventory, Recommendation, ProductProblemLink, and ProductKnowledge status/confidence/domain-status fields were not changed by that transfer.
- All 25 Evidence rows remained `PENDING / UNKNOWN`; no Evidence QA promotion occurred. ISDIN ProductKnowledge `ingredients` remained empty because no matching ingredients Evidence row was available.
- This supersedes older handoff wording that ProductKnowledge content fields were empty. That wording describes an earlier snapshot and must not be used as the present post-transfer state. A fresh local read-back is still required before claiming the saved content is currently verified.

### Anua — corrected evidence interpretation and proposed disposition
- The existing 24-assertion manifest remains the canonical research set; do not regenerate or re-import it. The 25th DB Evidence row is an additional duplicate Anua assertion, not a 25th canonical manifest assertion.
- Three relevant Anua Evidence records were identified:
  - `...-1ed73fb7`: the source-backed full INCI assertion in `ingredients`; retain this record.
  - `...-36d28c8a`: the manufacturer-declared 10% azelaic-acid claim in `manufacturer_claims`; retain this record.
  - `...-2b4c9e26`: a duplicate 10% manufacturer claim incorrectly classified under `ingredients`; this is the record designated for audited rejection from the active evidence set.
- Therefore, any earlier instruction or implication to remove `...-1ed73fb7` is incorrect and is superseded. Do not reject or delete the full-INCI record.
- The user has now requested that the Anua findings and correction be recorded and that inaccurate prior history be corrected. The intended data disposition is to retain `...-1ed73fb7` and `...-36d28c8a`, and reject `...-2b4c9e26` through the existing audited conflict-resolution service (not physical deletion).
- **Execution status:** this GitHub documentation update does not modify the local SQLite database. The Anua Evidence conflict must not be described as resolved until the local audited service operation is actually run and its post-write read-back confirms the exact intended rows and audit event. Verify the competing set before calling the service; no unrelated Evidence may be changed.

### Protected scope and next steps
- No Evidence QA promotion, no bulk status change, no migration, no code change, and no Inventory, Recommendation, ProductProblemLink, Product identity, or lifecycle mutation is authorized by this documentation correction.
- Obtain a fresh read-only local DB snapshot and ProductKnowledge read-back. For Anua, inspect the exact competing set, run only the audited correction described above, and verify the winner, rejected duplicate, audit event, and absence of unrelated changes.
- Issue #406 remains the single roadmap/source-of-truth issue and stays OPEN until its actual acceptance gates pass.
- Continue using this file as the sole active-session handoff. Do not create a parallel handoff document.


## Current Operational Handoff — post-merge correction — 2026-11-11

**Current master:** `40d24a37b7ffc8c46b860247d2da86ca856b4593`  
**Primary roadmap:** [Issue #406](https://github.com/vahidmaghsoudi2/hbi/issues/406) — OPEN  
**Runtime audit:** [Issue #74](https://github.com/vahidmaghsoudi2/hbi/issues/74) — CLOSED as `COMPLETE_WITH_OPERATIONAL_BLOCKERS`.

### PR #533 — merged and verified
- [PR #533](https://github.com/vahidmaghsoudi2/hbi/pull/533) was explicitly authorized by the PO and merged into `master`.
- Merge commit: `40d24a37b7ffc8c46b860247d2da86ca856b4593`; GitHub reports the commit signature as verified.
- Merged head: `2f0a2b7428149cf751d24e917fc9cfe0e91a1fe2`.
- PR state was re-read from GitHub: `closed`, `merged=true`; `refs/heads/master` points to the merge commit above.
- Exact PR-head checks before merge: HBI CI SUCCESS (755 passed, 88% coverage), HBI Auto Tasks SUCCESS (755 passed, 88% coverage), Pilot Browser Proof SUCCESS (30/30 browser tests; 61/61 parser conformance).
- Post-merge push workflows on the exact merge SHA both completed SUCCESS: [HBI CI run 43076211515](https://github.com/vahidmaghsoudi2/hbi/actions/runs/43076211515) and [HBI Auto Tasks run 43076211759](https://github.com/vahidmaghsoudi2/hbi/actions/runs/43076211759). CI jobs `test`, `governance-tests` and `g8-isolated-pilot-smoke` all report SUCCESS; Auto Tasks `Live test evidence` reports SUCCESS.
- The merge contains the audited ProductKnowledge derived-status refresh fix and this existing handoff file's earlier checkpoint update. The historical section below includes pre-merge wording; this top section supersedes it.
- No production DB, Evidence, ProductKnowledge content, QA state, inventory, Recommendation or lifecycle data was changed by PR #533.

### Latest conversation checkpoint — 2026-11-11

- User reviewed the low-resolution visual references for all seven canonical products.
- User confirmed references for products 1, 2, 4, 5, 6 and 7 as correct.
- User corrected product 3 (Garnier Vitamin C Brightening Gel Cleanser): the required package is **pump-type, not a tube**. A pump-package reference was subsequently shown and explicitly confirmed by the user. Record all seven visual references as user-confirmed, with product 3's pump packaging correction.
- This is package/visual confirmation only. Do not treat it as proof of exact market, formula, INCI, concentration, GTIN or product-variant identity. Product 3's precise pump SKU/market/formula remains to be independently matched against reliable source evidence.
- The latest read-only main-DB audit remains the supplied snapshot: SHA256 `c3f5df15fa3c3e15376e7627e43ba7730d9793e50782911ceddece147fceb556`, integrity `ok`, no FK violations, and unchanged before/after. Counts and acceptance blockers are recorded in the current conversation handoff; obtain a fresh read-only snapshot before making present-state claims.
- PR #533 is merged at `40d24a37b7ffc8c46b860247d2da86ca856b4593`; its post-merge HBI CI run `43076211515` and Auto Tasks run `43076211759` both completed SUCCESS.
- PR #534 remains OPEN, mergeable and unmerged. Its exact-head HBI CI run `43076543681` and Pilot Browser Proof run `43076543955` completed SUCCESS. It is documentation-only and still requires separate PO authorization to merge.
- No production DB, Evidence, ProductKnowledge content, QA, inventory, Recommendation or lifecycle data was changed as part of these visual confirmations or documentation updates.

### Immediate next actions
1. Resume the seven-product operational gates: fresh read-only DB snapshot; physical package/market/GTIN/INCI identity verification; human Evidence QA; accepted ProductKnowledge read-back; real sellable-stock confirmation; isolated seven-product Home Page E2E.
2. Continue resolving product 3's exact pump-package SKU/market/formula from authoritative source evidence; do not infer formula identity from packaging alone.
3. Keep Issue #406 OPEN until all product intake and acceptance gates are genuinely complete.
4. Do not run the unsafe PR #526 importer wrapper, start the app against the main DB, or write production DB, QA, inventory, lifecycle, Recommendation or ProductProblemLink data without explicit authorization and verified evidence.

### Continuity and safety fresh read-only DB snapshot; physical package/market/GTIN/INCI identity verification; human Evidence QA; accepted ProductKnowledge read-back; real sellable-stock confirmation; isolated seven-product Home Page E2E.
3. Keep Issue #406 OPEN until all product intake and acceptance gates are genuinely complete.
4. Do not run the unsafe PR #526 importer wrapper, start the app against the main DB, or write production DB, QA, inventory, lifecycle, Recommendation or ProductProblemLink data without explicit authorization and verified evidence.

### Continuity and safety
- Protect local modifications and all other worktrees; no reset, overwrite or cleanup.
- PowerShell diagnostics must copy all output via `Set-Clipboard` and also print it.
- After every six separate chats, append a concise six-chat summary to this same file; do not create parallel handoff documents.
- If connectivity is interrupted, resume from this file and Issue #406. PR #533 is merged; its merge SHA is `40d24a37b7ffc8c46b860247d2da86ca856b4593`.

---


## Current Operational Handoff — 2026-11-11

**Current master:** `a1176412717b13a680f62cf1b0fabc0e53337c69`  
**Primary roadmap:** [Issue #406](https://github.com/vahidmaghsoudi2/hbi/issues/406)  
**Completed runtime audit:** [Issue #74](https://github.com/vahidmaghsoudi2/hbi/issues/74) — closed as `COMPLETE_WITH_OPERATIONAL_BLOCKERS`.

### Latest code delivery
- [PR #533](https://github.com/vahidmaghsoudi2/hbi/pull/533) — fix stale ProductKnowledge conflict status after audited Evidence field reclassification.
- Branch: `fix/anua-reclassification-refresh-pk-conflict`.
- Implementation commit validated: `338e2e16fef70ae09ab879249ccca45438ec33e3`. A documentation-only handoff update is included in this PR; its new head must complete the same required checks before merge.
- PR is OPEN and mergeable; **not merged**. Merge requires explicit PO authorization.
- Exact implementation-head CI: [run 43073630350](https://github.com/vahidmaghsoudi2/hbi/actions/runs/43073630350) — SUCCESS, 755 passed, 88% coverage, compile/G8/governance/frontend build successful.
- Exact implementation-head Auto Tasks: [run 43073630307](https://github.com/vahidmaghsoudi2/hbi/actions/runs/43073630307) — SUCCESS, 755 passed, 88% coverage.
- Exact implementation-head Browser Proof: [run 43073630267](https://github.com/vahidmaghsoudi2/hbi/actions/runs/43073630267) — SUCCESS, 30/30 browser tests and 61/61 parser conformance records passed; isolated pilot smoke successful.
- PR #533 changes only derived ProductKnowledge conflict status after the final active Evidence conflict is removed. It preserves knowledge content/confidence and does not promote pending Evidence or QA.

### Product intake — unresolved operational gates
The latest user-provided read-only DB snapshot showed:
- Seven canonical skincare Products remain `DRAFT / NEEDS_REVIEW / PENDING`.
- ProductKnowledge content fields are empty; P7 Anua had `CONFLICT` status due concentration and INCI assertions sharing the `ingredients` field.
- 25 Evidence rows remain `PENDING / UNKNOWN`; Anua's two ingredient assertions were not QA-approved.
- All seven Inventory rows were `OUT_OF_STOCK`, with zero available quantity.
- No Recommendation or ProductProblemLink rows existed.
- Main DB was read-only, integrity `ok`, FK violations empty, and SHA256 before/after matched. No production DB mutation was performed.
- Treat this as the last supplied snapshot, **not proof of the present DB state**; obtain a fresh read-only snapshot before any acceptance decision.

### Seven canonical products
1. COSRX The 6 Peptide Skin Booster Serum
2. Neutrogena Clear & Defend 2% Salicylic Acid Face Wash
3. Garnier Vitamin C Brightening Gel Cleanser
4. SKIN1004 Madagascar Centella Hyalu-Cica Water-Fit Sun Serum
5. ISDIN FotoUltra 100 Active Unify SPF50+
6. Clinique Even Better Clinical Radical Dark Spot Corrector + Interrupter
7. Anua Azelaic Acid 10% + Hyaluron Redness Soothing Serum

### Remaining critical work, in order
1. PO decision: merge PR #533 after its updated exact-head CI/Auto Tasks/Browser checks are green.
2. Refresh the local DB snapshot read-only; do not run the unsafe PR #526 draft-import wrapper. PR #526 is closed and its expected draft Evidence rows were already present in the last snapshot.
3. Verify physical product identity/market/GTIN/formula from front/back/INCI/barcode package evidence for each of the seven products. Do not infer a formula from another market or variant.
4. Human QA review of source-bound Evidence; only approved Evidence may populate ProductKnowledge.
5. Confirm real stock and quantities before inventory adjustments.
6. Run isolated seven-product Home Page E2E and close the acceptance tracker only after PO acceptance.
7. PR #504 remains OPEN as the acceptance tracker only. Its implementation branch is stale/diverged and must not be merged or replayed; the older #513/#514/#516 fixes are already in master.
8. Keep Issue #406 open until the product intake and seven-product acceptance gates are actually complete.

### Safety and continuity rules
- No production DB writes, migrations, importer runs, lifecycle/QA promotion, inventory adjustment, or ProductProblemLink creation without explicit authorization and verified evidence.
- Never start the app against the main DB; app startup can initialize/migrate it. Use disposable SQLite for tests.
- Protect local modifications in `E:\HBI_GitHub_Current` and the other named worktrees; do not reset, overwrite, or clean them.
- For each PowerShell diagnostic, put all output in Clipboard via `Set-Clipboard` and also print it.
- After every six separate chats, append a concise six-chat summary to this same file; do not create parallel handoff documents.
- If connectivity is interrupted, resume from this file and Issue #406. PR #533 and exact-head run links above are the latest validated code checkpoint.

---


## Status
- **Last Updated:** 2026-08-20
- **Active Phase:** Technical Improvements (Post Phase-1 Hardening)
- **Previous:** GATE 9 / Phase 1 CLOSED successfully

## Official Kick-off (Qwen + PO) — 2026-08-20
Phase 1 closed successfully. Project now enters **Technical Improvements** phase to bullet-proof the system before production deployment.

### Locked PO Decisions (still in force)
- Products C & D remain **UNIDENTIFIED**
- No identity/evidence action for C/D until further PO instruction

---

## Technical Improvements — Assignments

### 1. DeepSeek (Backend)
- [ ] Fix StarletteDeprecationWarning (httpx related)
- [ ] Write Unit Tests for reasoning modules:
  - `app/reasoning/claim_validator.py`
  - `app/reasoning/reasoning_engine.py`
  - `app/reasoning/conflict_analyzer.py`
- [ ] Raise overall Coverage to **> 80%**

### 2. Perplexity (Evidence Steward / QA)
- [ ] Review new unit tests and confirm they strictly validate Framework 4 & 5 rules with **NO ASSUMPTION**
- [ ] Run final Coverage Report:
  ```bash
  pytest --cov=app --cov-report=term-missing
  ```
- [ ] Confirm threshold > 80% is met

### 3. All Members
- Strict **NO ASSUMPTION** principle
- Any conflict or missing information → Conflict Register + Source of Truth

---

## Current Reasoning Modules
| Module | Path | Test Coverage Status |
|---|---|---|
| claim_validator | app/reasoning/claim_validator.py | Needs dedicated unit tests |
| reasoning_engine | app/reasoning/reasoning_engine.py | Needs dedicated unit tests |
| conflict_analyzer | app/reasoning/conflict_analyzer.py | Needs dedicated unit tests |
| scoring | app/reasoning/scoring.py | Partial (test_scoring_engine.py exists) |

---

## Team Status

| Agent | Role | Current Task |
|---|---|---|
| DeepSeek | Backend | StarletteDeprecationWarning + Unit Tests for reasoning |
| Perplexity | QA / Evidence | Review tests + Final Coverage Report |
| Grok | Red Team / Support | Supporting Technical Improvements |
| Qwen | PM / Data QA | Coordination + receiving final reports |
| PO | Decision Maker | C/D locked UNIDENTIFIED |

---

## For AI Agent (Qwen)
1. Read this file first
2. Enforce NO ASSUMPTION
3. Accept only Artifact-based reports (especially full pytest --cov output)
4. Products C & D stay UNIDENTIFIED
5. Track DeepSeek unit tests + Perplexity coverage confirmation

## 2026-11-12 — Seven-product human review and controlled ProductKnowledge content transfer

### Decisions and research disposition carried forward
- The Product Owner accepted the seven product dossier drafts as the content basis. The seven human-review outcomes remain: Neutrogena, Garnier, COSRX, SKIN1004 and ISDIN accepted with stated limitations; Clinique and Anua accepted with explicit caveats.
- The product acceptance policy confirmed on 2026-11-11 remains authoritative: sufficiently clear commercial/model identity; collect ingredients, ingredient roles, use cases, evidence, limitations and important precautions; physical barcode/batch/package matching is not a universal acceptance prerequisite; investigate deeply only where ambiguity could materially cause a wrong recommendation or harm.
- Source hierarchy: manufacturer sources first; reliable distributor/retailer INCI when manufacturer detail is incomplete; scientific/specialist sources for context. Manufacturer claims remain distinct from independent evidence.
- The 24-assertion source manifest remains the existing research base. Do not regenerate or re-import it.
- Anua's 10% azelaic-acid concentration is accepted as a manufacturer-declared claim and ingredient assertion for dossier content. The two legacy Evidence rows remain technically conflicted and must not be silently reclassified or edited.
- Clinique remains the historical UK 100 ml product dossier, separate from its replacement serum. ISDIN's second INCI list remains the temporary reference and must not be merged with the first list.

### Local DB controlled write — 2026-11-12
The Product Owner explicitly authorized a content-only transfer into the seven existing ProductKnowledge rows. The local operator script reported:
- Transaction committed; exactly 7 existing ProductKnowledge rows updated.
- Only these eight columns were written: `ingredients`, `ingredient_roles`, `claimed_benefits`, `known_use_cases`, `usage_instructions`, `manufacturer_claims`, `contraindications`, `evidence_refs`.
- No Evidence row was promoted: all 25 remain `evidence_status=UNKNOWN` and `qa_status=PENDING`.
- The two Anua Evidence rows remain `conflict_status=CONFLICT`; Anua ProductKnowledge `evidence_status=CONFLICT` and `domain_evidence_status={"ingredients":"CONFLICT"}` were preserved.
- Product, Evidence, Inventory, Recommendation and ProductProblemLink were verified unchanged by the controlled-write script. ProductKnowledge status/confidence/domain-status fields were preserved.
- SQLite integrity check: `ok`; foreign-key violations: 0.
- Pre-write backup: `E:\\HBI_GitHub_Current\\artifacts\\hbi-before-productknowledge-write-20261112-001331.db`.
- ISDIN `ingredients` intentionally remains NULL because no ingredients Evidence row was available in the extracted 25-row set. Unsupported fields remain empty rather than being guessed.
- This transfer is an explicitly authorized content staging step; it does **not** mean Evidence QA, Product identity, lifecycle, inventory, recommendation eligibility, ProductProblemLink acceptance, or the seven-product operational acceptance gates are complete.

### Current roadmap position and next sequence
Issue #406 remains OPEN. The work is in **Phase 2 — sample product dossier completion**, with Phase 2 Gate 2 not yet closed. Continue in this order:
1. Read back the seven ProductKnowledge records from the local DB and verify the saved content, evidence references, caveats and intentionally empty fields against the accepted drafts. Do not alter Evidence/QA/conflict fields.
2. Obtain/inspect the physical product package details that materially resolve remaining identity or recommendation risks: front/back labels, visible INCI, market/region, size and GTIN where available. Keep unresolved market/formula identity as a caveat or NEEDS_REVIEW; do not infer formula from packaging alone.
3. Complete human QA of the 25 source-bound Evidence assertions individually. Accept/reject/retain caveats per assertion; do not bulk-promote and do not resolve Anua's two conflict rows without a separately authorized audited correction.
4. Refresh a read-only DB snapshot and verify ProductKnowledge read-back, Evidence/QA/conflict states, Product identity/lifecycle, inventory and protected tables.
5. Confirm actual sellable stock and quantities with the Product Owner before any inventory write. Current historical baseline had zero stock; do not assume stock has changed.
6. Only after identity, Evidence QA, knowledge and stock gates are satisfied, run the isolated seven-product Home Page E2E and obtain explicit Product Owner acceptance. Then assess evidence-supported ProductProblemLinks and recommendation acceptance under their own authorization boundaries.
7. Update Issue #406 with Gate 2/3/4 status based on observed evidence. Keep Issue #406 OPEN until all applicable intake and acceptance gates genuinely pass.

### Safety and continuity
- No migration, import, code change, Evidence QA promotion, conflict reclassification, Product identity/lifecycle change, inventory adjustment, Recommendation or ProductProblemLink write was performed by the ProductKnowledge content transfer.
- Do not run the unsafe legacy importer wrapper. Do not merge PR #534; it remains a documentation-only open handoff PR requiring separate PO authorization.
- The six-chat summary rule remains: after every six separate chats, append one concise summary to this same file. This checkpoint is recorded now so the current work is not lost.
